Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice

Abstract

These results show that murine-derived gene signatures can predict response even after accounting for common clinical variables and other predictive genomic signatures, suggesting that mice can be used to identify new biomarkers for human patients with cancer.